Ticker

No recent analyst price targets found for KORU.

Latest News for KORU

KORU Medical Systems Announces CEO Transition

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that following five years of service to the Company, Linda Tharby, President and Chief Executive Officer, will…

Business Wire • Mar 12, 2026
KORU Medical Systems Announces +20% Fourth Quarter and Full Year 2025 Revenue Growth, Positive Adjusted EBITDA and Initiates Full Year 2026 Guidance

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the fourth quarter and full year ended December 31, 2025. The Company also initiated…

Business Wire • Mar 12, 2026
3 Reasons This South Korea ETF Is up Over 100% YTD

Volatility continues to rain down on the markets, but there are some shining stars in the bullish leveraged ETF arena. One particular standout is the Direxion Daily South Korea Bull 3X Shares (KORU), which is up over 100% for the year and nearly 400% within the past six months.

ETF Trends • Mar 10, 2026
Top Performing Leveraged/Inverse ETFs: 03/01/2026

Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

ETF Trends • Mar 3, 2026

🧮 Earnings Move Analyzer

Insider Trading

No insider trades found for KORU.

No Senate trades found for KORU.

No House trades found for KORU.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top